ClinConnect ClinConnect Logo
Search / Trial NCT04246944

Induced Membrane Properties in Children and Adults

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Jan 28, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Induced Membrane Critical Size Defect

ClinConnect Summary

**Summary of the Clinical Trial: Induced Membrane Properties in Children and Adults**

This clinical trial is studying a new way to help heal bone injuries that are too large to heal on their own, known as critical sized defects. The Masquelet technique, which is being researched, involves a two-step process. First, a special spacer is placed in the bone defect, which helps the body form a natural membrane around it. After some time, the spacer is removed, and the area is filled with bone graft material to support healing. Researchers want to learn more about how this membrane helps with blood flow and bone healing in both children and adults.

If you or a family member have a critical sized bone defect and are between the ages of 9 months and 60 years, you might be eligible to participate in this study at CHU Amiens-Picardie. However, those who are pregnant, nursing, or have other issues like being under guardianship can't join. Participants will be closely monitored throughout the study to understand how well this technique works. It's an opportunity to contribute to important research that could improve bone healing methods in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients treated at CHU Amiens-Picardie for bone critical sized defect treated using the induced membrane reconstruction technique.
  • patients from 9 months to 60 years old
  • Exclusion Criteria:
  • Patients managed by another reconstruction technique for critical sized defect
  • Patients under guardianship, curators or deprived of liberty.
  • Pregnant and nursing women.
  • Patients who refused to participate in the study and to sign informed consent.

About Centre Hospitalier Universitaire, Amiens

The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.

Locations

Amiens, , France

Patients applied

0 patients applied

Trial Officials

Céline Klein, MD

Principal Investigator

CHU Amiens

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials